QDEL vs TALK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
QuidelOrtho exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a technical trend score of 0/100. Despite appearing 'cheap' on a Price-to-Book (0.45) and Price-to-Sales (0.32) basis, the company suffers from negative profit margins (-41.45%) and a catastrophic 5-year price decline of 89.6%. The disconnect between the bullish analyst target ($30.83) and the deteriorating fundamental health suggests a classic value trap. The lack of revenue growth (2.2%) and negative ROE (-46.15%) further undermine any recovery thesis.
TALK presents a classic growth-vs-value conflict. While the Piotroski F-Score of 4/9 indicates stable financial health and the company has successfully transitioned to profitability with explosive earnings growth (181% YoY), the valuation is disconnected from deterministic baselines. The stock trades at $5.18, significantly exceeding both the Graham Number ($0.79) and Intrinsic Value ($1.18), suggesting a massive growth premium. Strong liquidity (Current Ratio 6.38) offsets the lack of an Altman Z-Score, but bearish insider activity and a weak technical trend temper the bullish growth narrative.
Compare Another Pair
Related Comparisons
QDEL vs TALK: Head-to-Head Comparison
This page compares QuidelOrtho Corporation (QDEL) and Talkspace, Inc. (TALK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.